Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
4.430
+0.010 (0.23%)
Nov 21, 2024, 2:24 PM EST - Market open
Adaptive Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 177.28 | 170.28 | 185.31 | 154.34 | 98.38 | 85.07 | Upgrade
|
| Revenue Growth (YoY) | -1.34% | -8.11% | 20.06% | 56.88% | 15.65% | 52.83% | Upgrade
|
| Cost of Revenue | 182.16 | 197.67 | 199.67 | 191.64 | 138.6 | 92.98 | Upgrade
|
| Gross Profit | -4.88 | -27.39 | -14.36 | -37.3 | -40.22 | -7.91 | Upgrade
|
| Selling, General & Admin | 160.57 | 172.51 | 184.13 | 169.97 | 110.89 | 68.79 | Upgrade
|
| Operating Expenses | 162.27 | 174.21 | 185.83 | 171.67 | 112.6 | 70.48 | Upgrade
|
| Operating Income | -167.15 | -201.61 | -200.19 | -208.97 | -152.82 | -78.39 | Upgrade
|
| Interest Expense | -11.64 | -13.8 | -4.24 | - | - | - | Upgrade
|
| Interest & Investment Income | 6.37 | 6.35 | 4.8 | 8.9 | 7.36 | 7.59 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | -2.27 | Upgrade
|
| EBT Excluding Unusual Items | -172.42 | -209.06 | -199.63 | -200.07 | -145.45 | -73.07 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.71 | 9.18 | -0.74 | -7.23 | -0.77 | 4.46 | Upgrade
|
| Asset Writedown | -32.63 | -25.43 | - | - | - | - | Upgrade
|
| Pretax Income | -195.35 | -225.3 | -200.37 | -207.3 | -146.23 | -68.61 | Upgrade
|
| Earnings From Continuing Operations | -195.35 | -225.3 | -200.37 | -207.3 | -146.23 | -68.61 | Upgrade
|
| Minority Interest in Earnings | 0.1 | 0.05 | 0.18 | 0.02 | - | - | Upgrade
|
| Net Income | -195.24 | -225.25 | -200.19 | -207.28 | -146.23 | -68.61 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.96 | Upgrade
|
| Net Income to Common | -195.24 | -225.25 | -200.19 | -207.28 | -146.23 | -69.57 | Upgrade
|
| Shares Outstanding (Basic) | 146 | 144 | 143 | 140 | 131 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 146 | 144 | 143 | 140 | 131 | 69 | Upgrade
|
| Shares Change (YoY) | 1.73% | 1.31% | 1.54% | 6.96% | 89.71% | 447.64% | Upgrade
|
| EPS (Basic) | -1.33 | -1.56 | -1.40 | -1.48 | -1.11 | -1.01 | Upgrade
|
| EPS (Diluted) | -1.34 | -1.56 | -1.40 | -1.48 | -1.11 | -1.01 | Upgrade
|
| Free Cash Flow | -114.54 | -167.02 | -200.29 | -254.47 | -168.49 | 194.2 | Upgrade
|
| Free Cash Flow Per Share | -0.78 | -1.16 | -1.41 | -1.81 | -1.28 | 2.81 | Upgrade
|
| Gross Margin | -2.75% | -16.09% | -7.75% | -24.17% | -40.88% | -9.30% | Upgrade
|
| Operating Margin | -94.28% | -118.40% | -108.03% | -135.39% | -155.33% | -92.15% | Upgrade
|
| Profit Margin | -110.13% | -132.29% | -108.03% | -134.30% | -148.63% | -81.78% | Upgrade
|
| Free Cash Flow Margin | -64.61% | -98.09% | -108.09% | -164.87% | -171.26% | 228.28% | Upgrade
|
| EBITDA | -146.95 | -179.38 | -179.27 | -195.01 | -144.35 | -70.6 | Upgrade
|
| EBITDA Margin | -82.89% | -105.34% | -96.74% | -126.35% | -146.72% | -82.99% | Upgrade
|
| D&A For EBITDA | 20.2 | 22.23 | 20.92 | 13.95 | 8.47 | 7.79 | Upgrade
|
| EBIT | -167.15 | -201.61 | -200.19 | -208.97 | -152.82 | -78.39 | Upgrade
|
| EBIT Margin | -94.28% | -118.40% | -108.03% | -135.39% | -155.33% | -92.15% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 85.07 | Upgrade
|
| Advertising Expenses | - | - | - | - | 14.5 | 6.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.